ReviewGraves' ophthalmopathy. A clinical and immunologic review☆
References (134)
- et al.
Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease
Am J Med
(1963) The long-acting thyroid stimulator of Graves' disease
Am J Med
(1968)Excylotropia in dysthyroid ophthalmopathy
Am J Ophthalmol
(1972)Advances in the laboratory diagnoses of thyroid disease
J Pediatr
(1973)Advances in the laboratory diagnoses of thyroid disease
J Pediatr
(1973)Anti-receptor antibodies as a mechanism of disease
Endocrine exophthalmos
Br Med J
(1972)- et al.
Acquired immunologic deficiencies after trauma and surgical procedures
Surg Gynecol Obstet
(1974) - et al.
Binding of thyroglobulin and thyroglobulin-anti-thyroglobulin immune complex to extraocular muscle membrane
Endocrinology
(1975) - et al.
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves' ophthalmopathy
- et al.
Relationship of long-acting thyroid stimulation to the clinical features and course of Graves' disease
Am J Med
(1967)
Postural changes in intraocular pressure in dysthyroid exophthalmos
Trans Ophthalmol Soc UK
(1971)
Long-acting thyroid stimulator of Graves' disease
Pinealomas and tumors of the posterior portion of the third ventricle
J Neurosurg
(1968)
Stimulation of the human thyroid by infusions of plasma containing LATS protector
J Clin Endocrinol Metab
(1974)
Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland
J Clin Endocrinol Metab
(1967)
The experimental production of exophthalmos in fundulus by means of pituitary extracts
Endocrinology
(1945)
Hypothyroidism in progressive ophthalmopathy of Graves' disease
Acta Ophthalmol
(1972)
Management of thyrotoxicosis in patients with ophthalmopathy: antithyroid regimen determined primarily by ocular manifestations
J Clin Endocrinol Metab
(1965)
Ophthalmopathy of Graves' disease: outcome after treatment with radioactive iodine, surgery or antithyroid drugs
Arch Intern Med
(1972)
Thyroid function in patients with progressive exophthalmos
Clinical immunology of Hashimoto's disease
A modified Krönlein operation
Trans Am Ophthalmol Soc
(1953)
Compt Rend Soc Bio
(1852)
Cyclophosphamide in the management of advanced Graves' ophthalmopathy
Ann Intern Med
(1979)
Thyrotoxicosis occurring in two patients on prolonged high doses of steroid
N Engl J Med
(1964)
Immunologic functions of isolated human lymphocyte populations. IV. Further characterization of the surface Ig negative, E rosette negative (null cell) subset
J Immunol
(1975)
Specific and non-specific responses in the bioassay of long-acting thyroid stimulator (LATS)
J Clin Endocrinol Metab
(1970)
A developmental approach to the biological basis of antibody diversity
Contemp Top Immunobiol
(1972)
Optic nerve involvement associated with thyroid dysfunction
Arch Ophthalmol
(1962)
Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction
Arch Ophthalmol
(1968)
Hyperthyroidism: pathology of eye changes
Ocular manifestations of Graves' disease — therapeutic approaches
Bull NY Acad Med
(1977)
Surgical palliation of ophthalmopathy of Graves' disease
Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism
Brith Defects
(1968)
The use of thymoxamine in eyelid retraction
Arch Ophthalmol
(1979)
Supervoltage orbital radiotherapy for Graves' ophthalmopathy
J Clin Endocrinol Metab
(1973)
The use of scleral transplantation in cicatricial entropion and eyelid retraction
Trans Am Acad Ophthalmol Otolaryngol
(1977)
Psychic manifestations associated with hyperthyroidism
Am J Psychiatr
(1935)
Peripheral thymusderived (T) lymphocytes in Graves' disease and Hashimoto's thyroiditis
N Engl J Med
(1973)
The splenic suppressor cell. II. Suppression of the mixed lymphocyte reaction by thymus-dependent adherent cells
J Immunol
(1974)
Chorioretinal folds
Visual field defects associated with choroidal folds
On the increased association of Graves' disease with pernicious anemia
Myasthenia gravis and thyroid function
Arch Neurol
(1968)
Topical sympatholytic therapy for pathologic lid retraction
Arch Ophthalmol
(1967)
Topical guanethidine therapy for endocrine lid retraction
Arch Ophthalmol
(1966)
T-cell control of antibody production
Contemp Top Immunobiol
(1974)
Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct
Principles of radioimmunoassay
Cited by (79)
Endoscopic orbital decompression
2011, Operative Techniques in Otolaryngology - Head and Neck SurgeryCitation Excerpt :After the inflammatory process ends, fibrosis and the associated disabling symptoms persist in the stable, inactive phase. Immunomodulatory agents are believed to affect the activity of orbital lymphocytes and fibroblasts.7,8 The most commonly used immunomodulators include corticosteroids with or without adjunctive external beam orbital radiation (XRT) in moderate to severe cases of TED.
Reversible Horner's syndrome and dysthyroid ocular myopathy associated with Hashimoto's disease
2003, Japanese Journal of OphthalmologyChange in eyelid parameters after orbital decompression in thyroid-associated orbitopathy
2018, Eye (Basingstoke)Autoimmune hyperthyroidism and thyroid eye disease: What is the role of pro-oxidants and antioxidants?
2015, Expert Review of OphthalmologyCompressive and infiltrative optic neuropathies
2014, Optic Nerve Disorders: Diagnosis and Management
- ☆
Part of the investigative work contained in this review was supported by National Eye Institute Grant EY 02631.
- 1
Dr. Sergott is the recipient of a National Research Service Award (EY 07021) from the National Eye Institute
Copyright © 1981 Published by Elsevier Inc.